Lymphocyte-mediated immune responses in neoplasia.
D000818:Animals; D000937:Antigen-Antibody Reactions; D000951:Antigens, Neoplasm; D000961:Antilymphocyte Serum; D003165:Complement System Proteins; D003601:Cytotoxicity Tests, Immunologic; D003888:Desensitization, Immunologic; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007109:Immunity / Q000187:drug effects; D007111:Immunity, Cellular; D007112:Immunity, Maternally-Acquired; D007158:Immunologic Techniques; D066298:In Vitro Techniques; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology*; D008222:Lymphokines / Q000302:isolation & purification; D009368:Neoplasm Transplantation; D009369:Neoplasms / Q000097:blood / Q000276:immunology* / Q000473:pathology; D009374:Neoplasms, Experimental / Q000276:immunology; D012334:RNA, Neoplasm / Q000494:pharmacology; D012882:Skin Tests; D014184:Transplantation, Homologous
D000951:Antigens, Neoplasm; D000961:Antilymphocyte Serum; D008222:Lymphokines; D012334:RNA, Neoplasm; D003165:Complement System Proteins